NCT05336006

Brief Summary

The coronavirus disease (COVID-19), is a communicable pandemic disease as stated by the world health organization (WHO), which has been affecting the world since December 2019. COVID-19 infected children develop the signs and symptoms of the disease, which can be exaggerated or life-threatening when associated with comorbidities like; obesity, sickle cell anemia, immune disorders, chromosomal abnormalities, chronic respiratory or cardiac problems, and congenital malformations.3 It is observed that children affected with COVID-19 who are physically inactive or in a sedentary lifestyle may induce and develop obesity. It is a major health concern in this pandemic situation, which can be addressed and treated with the use of appropriate physical training and proper dietary habits.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 10, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2020

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 5, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 20, 2022

Completed
Last Updated

April 27, 2022

Status Verified

April 1, 2022

Enrollment Period

10 months

First QC Date

April 5, 2022

Last Update Submit

April 20, 2022

Conditions

Keywords

aerobic trainingbiochemicalchildren with obesityCOVID-19high protein diet

Outcome Measures

Primary Outcomes (3)

  • Body mass index (BMI)

    For children, age adjusted BMI percentile (BMI %) was calculated, which is a reliable and valid measurement to measure the stage of obesity.

    At baseline

  • Body mass index (BMI)

    For children, age adjusted BMI percentile (BMI %) was calculated, which is a reliable and valid measurement to measure the stage of obesity.

    8 weeks

  • Body mass index (BMI)

    For children, age adjusted BMI percentile (BMI %) was calculated, which is a reliable and valid measurement to measure the stage of obesity.

    6 months

Secondary Outcomes (15)

  • Muscle cross sectional area - CSA

    At baseline

  • Muscle cross sectional area - CSA

    8 weeks

  • Muscle cross sectional area - CSA

    6 months.

  • Adiponectin

    At baseline

  • Adiponectin

    8 weeks

  • +10 more secondary outcomes

Study Arms (2)

High-intensity aerobic training with high protein diet - Group A

EXPERIMENTAL

High-intensity aerobic training (HAT) was given at 50 to 70 percent of maximum heart rate. Subsequent to stretching, the subjects were asked to do 30 mins of HAT exercises; consisting of 20 mins on the treadmill and 10 mins on a cycle ergometer at 50 to 70 % of MHR, lastly, 10 mins of cool down was performed. Next the participants, in this group A were prescribed with strength training exercises with resistance depending upon each subject's individual muscle assessment. In addition to these physical training exercises, this group also received a high protein diet in the range of 1.1 - 1.3 g/kg protein/ ideal body weight/day (\>1 g/kg aBW/d), as prescribed by a qualified nutritionist.

Other: High-intensity aerobic training with high protein diet

Control group - Group B

PLACEBO COMPARATOR

This group is considered a control group and they were allowed to follow their regular physical activities and dietary pattern.

Other: Control group

Interventions

High-intensity aerobic training (HAT) was given at 50 to 70 percent of maximum heart rate. Subsequent to stretching, the subjects were asked to do 30 mins of HAT exercises; consisting of 20 mins on the treadmill and 10 mins on a cycle ergometer at 50 to 70 % of MHR, lastly, 10 mins of cool down was performed. Next the participants, in this group A were prescribed with strength training exercises with resistance depending upon each subject's individual muscle assessment. In addition to these physical training exercises, this group also received a high protein diet in the range of 1.1 - 1.3 g/kg protein/ ideal body weight/day (\>1 g/kg aBW/d), as prescribed by a qualified nutritionist.

High-intensity aerobic training with high protein diet - Group A

This group is considered a control group and they were allowed to follow their regular physical activities and dietary pattern.

Control group - Group B

Eligibility Criteria

Age5 Years - 12 Years
Sexmale
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Positively diagnosed COVID-19 children
  • age group of 5 - 12 years
  • Body mass index (BMI) between 85th to 99th percentiles

You may not qualify if:

  • history of physical training,
  • taking medications,
  • recent surgeries,
  • fractures and joint problems in the lower extremity,
  • cardiac and respiratory problems,
  • neurological issues,
  • major psychiatric problems,
  • other systemic diseases,
  • contraindications for physical training and family with food restrictions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gopal Nambi

Al Kharj, Riyadh Region, 11942, Saudi Arabia

Location

MeSH Terms

Conditions

Pediatric ObesityCOVID-19

Interventions

Diet, High-ProteinControl Groups

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 5, 2022

First Posted

April 20, 2022

Study Start

March 10, 2020

Primary Completion

December 25, 2020

Study Completion

October 30, 2021

Last Updated

April 27, 2022

Record last verified: 2022-04

Locations